Market Overview

Alexion Pharma Shares Bounce as Lazard Upgraded to Buy, Sets $102 Price Target

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ALXN

DateFirmActionFromTo
Nov 2014JP MorganMaintainsOverweight
Sep 2014SunTrust Robinson HumphreyInitiates Coverage onBuy
Jul 2014Credit SuisseMaintainsNeutral

View More Analyst Ratings for ALXN
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (ALXN)

Around the Web, We're Loving...

Get Benzinga's Newsletters